Navigation Links
Blue Cross and Blue Shield of Florida Reports Eighteenth Consecutive Year of Positive Performance
Date:9/11/2007

JACKSONVILLE, Fla., Sept. 11 /PRNewswire/ -- In remarks presented today during Blue Cross and Blue Shield of Florida's (BCBSF) annual policyholders' meeting, Chris Doerr, Executive Vice President, Chief Administrative Officer and Chief Financial Officer, reported that 2006 marked the company's eighteenth consecutive year of positive performance.

(Logo: http://www.newscom.com/cgi-bin/prnh/20000427/BLUELOGOA )

(Logo: http://www.newscom.com/cgi-bin/prnh/20000427/BLUELOGOB )

Doerr said the company increased enrollment in its Health Business by more than 308,000 new members, posted positive financial gains and enhanced policyholders' equity.

"Blue Cross and Blue Shield of Florida has a unique role in advancing the health and well-being of Floridians. Our corporate mission calls for a greater commitment to the public good. It is within the framework of our mission that we focus on our ultimate goal, which is providing our members access to quality, affordable health care," said Doerr.

Doerr confirmed BCBSF's commitment to creating innovative and cost effective products, delivering superior customer service, and increasing satisfaction among members, physicians and providers, employers, distribution channels and other partners.

In other business conducted at the meeting related to the BCBSF Board of Directors, DuBose Ausley was re-elected to a one-year term, Edward L. Boykin, Tracy A. Leinbach and Frank P. Scruggs, Jr. were re-elected to two-year terms, and Catherine P. Bessant, Barbara S. Thomas and Gonzalo F. Valdes-Fauli were re-elected to three-year terms. Other board activity announced today included the retirement of board members Henry H. Beckwith, who served for 21 years, and Yank D. Coble, Jr., M.D. (Director Emeritus), who served for 13 years.

Blue Cro
'/>"/>

SOURCE Blue Cross and Blue Shield of Florida
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine news :

1. Memory problem? solve a crossword
2. FDA attacks American Red Cross for blood violations
3. Encephalitis Death Toll In U.P. Crosses 200 Mark.
4. Encephalitis Deaths Cross 220 in Uttar Pradesh
5. Flu-Drugs Are Causing Resistance Across The World
6. Condom Vending Machines To Be Installed Across Indian States
7. First Crossover Kidney Transplantation In Germany
8. Bird Flu Infection Of Chinese Girl Prompts Fear Of Spread Across Asia
9. Chicken pox Spreads Across Firozabad
10. The Cleveland Clinic Expands Its Services across the World via the Net
11. Blue Cross Signs Up 110,000 Minnesotans For Part D Medicare Plans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2008)...y 21 /PRNewswire-FirstCall/ -- Aflac Incorporated,...presentation at the Sanford,C. Bernstein & Co., LL...nce,2008., President and Chief Financial Officer ...ted, and he is scheduled to make a presentation on...orated presentation, Mr.,Cloninger will discuss th...
(Date:5/21/2008)...d SILVER SPRING, Md., May 21 /PRNewswire-USNewswir... (ADAA),( http://www.adaa.org ) and The HealthCent... announced that ADAA will join,HealthCentral,s gro...and,health experts dedicated to helping people suf... advice and support they need to cope with the,con...
(Date:5/21/2008)...s 1st quarter profit, enhanced operations and new ...ELES, May 21 /PRNewswire-FirstCall/ -- InstaCare C...butor of at-home testing diagnostics,for the chron...eveloper of,patent-pending technologies for e-heal...s for the first quarter period-ended March 31, 200...
(Date:5/21/2008)... Adverse Events in TORCH Showed Frequency Highest ...ONTO and RESEARCH TRIANGLE PARK, N.C., May 21 /PRN...500/50 (fluticasone propionate and,salmeterol inha...er of,cardiovascular adverse events compared to ot...from the TOwards a Revolution in COPD Health,(TORC...
Breaking Medicine News(10 mins):Health News:Aflac Incorporated to Present at the Sanford C. Bernstein & Co., LLC Twenty-Fourth Annual Strategic Decisions Conference 2008 2Health News:The Anxiety Disorders Association of America and The HealthCentral Network Form Alliance to Develop New Online Resources for Anxiety Disorders 2Health News:The Anxiety Disorders Association of America and The HealthCentral Network Form Alliance to Develop New Online Resources for Anxiety Disorders 3Health News:InstaCare Corp. in Turnaround Reports 258% Revenues Increase in 1Q 2008 2Health News:InstaCare Corp. in Turnaround Reports 258% Revenues Increase in 1Q 2008 3Health News:InstaCare Corp. in Turnaround Reports 258% Revenues Increase in 1Q 2008 4Health News:InstaCare Corp. in Turnaround Reports 258% Revenues Increase in 1Q 2008 5Health News:Three-Year COPD Study Found No Increase in Cardiac Events With Advair(R) 500/50 2Health News:Three-Year COPD Study Found No Increase in Cardiac Events With Advair(R) 500/50 3
...f contagious skin infections, the threat of pandem...oap and Detergent Association (SDA) to issue its s...a “C-minus”, a downgrade from 2004, when the count...nt than ever that people understand that clean han...
...eptember issue of Mayo Clinic Proceedings says tha..., all intravascular devices (IVDs) have an inheren...dult patients. An IVD is any device that allows ac...ter is the most commonly used device. As many as 5...
...called enzymes catalyze specific biochemical react...mic fluctuations//protein conformation or structur...recent findings reveal that it is the "dynamic ene... specific pathway that reduces the number and dime...
...d on Monday at a local hospital in Tulungagung, Ea...Health Ministry officials confirmed yesterday.// R...information center told Reuters that the boy had c...ts confirmed that he died to H5N1 virus infection....
Other Medicine News:Health News:America’s Clean Hands Report Card - Can’t Rise Above ‘C’ L 2Health News:America’s Clean Hands Report Card - Can’t Rise Above ‘C’ L 3Health News:Infection Risk High With All IVDs 2Health News:"Dynamic Energy Landscape" of enzyme in Catalysis 2
(Date:5/21/2008)... HILDEN, Germany, May 21 /...V Test as Front-line,Screen, Long-term data from ...Cancer show that women screened only with a human ...o develop moderate to severe cervical disease over...onal cytology (the Pap,"smear"). The research foll...
(Date:5/20/2008)...Statistically Significant Reduction of IBS Pain an...Effect Observed, SAN DIEGO, May 20 /...results of a recent Phase 2b study of its oral kap...onstrated statistically significant,results in the...adoline,produced significant improvement in diarrh...
(Date:5/20/2008)... 94 Percent of Men Maintained Normal Testosteron...Treatment 92 Percent of Men Expressed Sat...- Indevus,Pharmaceuticals, ... NEBIDO(R),(testosterone undecanoate), an investig...he treatment of hypogonadism, was presented in a l...
(Date:5/20/2008)...ata on Newly-Approved Cimzia(R) Presented at Diges...swire/ -- UCB announced today that data,presented ...sustainable,efficacy and safety of Cimzia(R) (cert...ts with moderate to severe Crohn,s disease. Data a...y of responders and the remission,rate remained st...
Breaking Medicine Technology:Study Finds QIAGEN's HPV Test Offers Greater Long-term Protection From Cervical Disease Than the Pap 2Study Finds QIAGEN's HPV Test Offers Greater Long-term Protection From Cervical Disease Than the Pap 3Study Finds QIAGEN's HPV Test Offers Greater Long-term Protection From Cervical Disease Than the Pap 4Tioga Pharmaceuticals' Asimadoline Demonstrates Positive Results in a Phase 2b Clinical Trial for the Treatment of Irritable Bowel Syndrome 2Tioga Pharmaceuticals' Asimadoline Demonstrates Positive Results in a Phase 2b Clinical Trial for the Treatment of Irritable Bowel Syndrome 3Tioga Pharmaceuticals' Asimadoline Demonstrates Positive Results in a Phase 2b Clinical Trial for the Treatment of Irritable Bowel Syndrome 4Indevus Presents Successful Phase III NEBIDO(R) Data at American Urological Association 2Indevus Presents Successful Phase III NEBIDO(R) Data at American Urological Association 3Indevus Presents Successful Phase III NEBIDO(R) Data at American Urological Association 4Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohn's Disease 2Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohn's Disease 3Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohn's Disease 4Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohn's Disease 5Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohn's Disease 6Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohn's Disease 7Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohn's Disease 8BLU MED Announces New Medical Preparedness Contracts 7283 1BLU MED Announces New Medical Preparedness Contracts 7283 2BioSpace Launches 2nd Edition of Southern Pharm 28TM 29 Hotbed Campaign 2027 1BioSpace Launches 2nd Edition of Southern Pharm 28TM 29 Hotbed Campaign 2027 2U S Patent 7 299 083 Awarded to Signalife 2023 1U S Patent 7 299 083 Awarded to Signalife 2023 2FDA Approves Cymbalta 28R 29 for Maintenance Treatment of Major Depressive Disorder 953 1FDA Approves Cymbalta 28R 29 for Maintenance Treatment of Major Depressive Disorder 953 2FDA Approves Cymbalta 28R 29 for Maintenance Treatment of Major Depressive Disorder 953 3FDA Approves Cymbalta 28R 29 for Maintenance Treatment of Major Depressive Disorder 953 4
...uture Pandemics , ,BETHESDA, Md., April 2, 2007--O...anish influenza pandemic is why it struck differen...cipalities such as,St. Louis spared the fate of th...emented similar public health measures? What made ...es funded by the,National Institutes of Health (NI...
...ent Therapy Significantly,Improved Absorption of F...y and DAYTON, Ohio, April 04, 2007 /PRNewswire/ --..., today unveiled,data from two phase III clinical ... formerly EUR-1008, for the treatment of,Exocrine ...ug,Administration (FDA) granted fast track status ...
Other Medicine Technology:Rapid Response was Crucial to Containing the 1918 Flu Pandemic 2Rapid Response was Crucial to Containing the 1918 Flu Pandemic 3Rapid Response was Crucial to Containing the 1918 Flu Pandemic 4Rapid Response was Crucial to Containing the 1918 Flu Pandemic 5Eurand Announces Positive Phase III Clinical Study Results 2Eurand Announces Positive Phase III Clinical Study Results 3Eurand Announces Positive Phase III Clinical Study Results 4Eurand Announces Positive Phase III Clinical Study Results 5
The Guidant INSIGNIA Ultra pacing system offers sophisticated patient-specific, easy-to-use features for simplified patient management and enhanced patient safety.
The 5500s electronic architecture incorporates advanced circuit designs optimized for efficiency and function. We call it HI VUE an engineering philosophy that directs the development of each subsys
The HI VISION 6500 high resolution digital ultrasound system offers advanced clinical imaging, enhanced operating efficiency, and remarkable clinical flexibility, all in robust and versatile configur
...features of the ELECTRA 1400C are designed to achi...away capabilities. This system includes automated ...nogen and factor assays in a single setup. It also...eparation of reference curves and patient sample d...
Medicine Products: